Skip to main content
Log in

Antidepressant use and the risk of seizure: a meta-analysis of observational studies

  • Review
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The association between antidepressant use and the risk of seizures remains controversial. Therefore, this meta-analysis examined whether antidepressant use affects the risk of seizures.

Methods

To identify relevant observational studies, we conducted systematic searches in PubMed and Embase of studies published through May 2023. Random-effects models were used to estimate overall relative risk.

Results

Our meta-analysis included eight studies involving 1,709,878 individuals. Our results showed that selective serotonin reuptake inhibitors (SSRI) (odds ratio [OR] 1.48, 95% confidence interval [CI] 1.32–1.66; P < 0.001) and selective noradrenalin reuptake inhibitors (SNRI) (OR 1.65, 95% CI 1.24–2.19; P = 0.001), but not tricyclic antidepressants (TCA) (OR 1.27, 95% CI 0.84–1.92; P = 0.249), were associated with an increased risk of seizures. Subgroup analyses revealed an OR of 2.35 (95% CI 1.7, 3.24; P < 0.001) among short-term (< 30 days) antidepressant users.

Conclusions

The findings of this meta-analysis support an increased risk of seizures in new-generation antidepressant users, expanding previous knowledge by demonstrating a more pronounced risk in short-term users.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Harmer CJ, Duman RS, Cowen PJ (2017) How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry 4(5):409–418. https://doi.org/10.1016/s2215-0366(17)30015-9

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kazdin AE, Wu CS, Hwang I, Puac-Polanco V, Sampson NA, Al-Hamzawi A, Alonso J, Andrade LH, Benjet C, Caldas-de-Almeida JM, de Girolamo G, de Jonge P, Florescu S, Gureje O, Haro JM, Harris MG, Karam EG, Karam G, Kovess-Masfety V, Lee S, McGrath JJ, Navarro-Mateu F, Nishi D, Oladeji BD, Posada-Villa J, Stein DJ, Üstün TB, Vigo DV, Zarkov Z, Zaslavsky AM, Kessler RC (2023) Antidepressant use in low- middle- and high-income countries: a World Mental health surveys report. Psychol Med 53(4):1583–1591. https://doi.org/10.1017/s0033291721003160

    Article  PubMed  Google Scholar 

  3. Kumar M, Bajpai R, Shaik AR, Srivastava S, Vohora D (2020) Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis. Eur J Clin Pharmacol 76(10):1373–1392. https://doi.org/10.1007/s00228-020-02893-1

    Article  PubMed  Google Scholar 

  4. Wang XY, Ying XH, Jiang HY (2023) Antidepressant use during pregnancy and the risk for gestational Diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 36(1):2162817. https://doi.org/10.1080/14767058.2022.2162817

    Article  PubMed  Google Scholar 

  5. Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, Zhang YH, Ruan B (2015) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 13(1):42–50e43. https://doi.org/10.1016/j.cgh.2014.06.021

    Article  PubMed  CAS  Google Scholar 

  6. Elger CE, Hoppe C (2018) Diagnostic challenges in Epilepsy: seizure under-reporting and seizure detection. Lancet Neurol 17(3):279–288. https://doi.org/10.1016/s1474-4422(18)30038-3

    Article  PubMed  Google Scholar 

  7. Larson EA, Accardi MV, Zhong Y, Paquette D, Authier S (2021) Drug-Induced seizures: considerations for underlying Molecular mechanisms. Int J Toxicol 40(5):403–412. https://doi.org/10.1177/10915818211040483

    Article  PubMed  CAS  Google Scholar 

  8. Magli G, Conti M, Polano R, Luzzu G, Fadda M, Sotgiu S, Casellato S (2021) Seizures associated with selective serotonin reuptake inhibitors: a case of pharmacologically induced epileptic myoclonia. Seizure 88:75–77. https://doi.org/10.1016/j.seizure.2021.03.031

    Article  PubMed  Google Scholar 

  9. Saffaei D, Lovett S, Rech MA (2020) New-Onset Seizure in Patient Medicated with Bupropion for Smoking Cessation: a Case Report. J Emerg Med 58(3):e145–e147. https://doi.org/10.1016/j.jemermed.2019.12.020

    Article  PubMed  Google Scholar 

  10. Ye C, Ninneman M, Christian JS, Zhang F, Musselman D (2018) Seizure Induced by a therapeutic dose of Venlafaxine ER: a Case Report. J Psychiatr Pract 24(2):117–120. https://doi.org/10.1097/pra.0000000000000298

    Article  PubMed  Google Scholar 

  11. Hill T, Coupland C, Morriss R, Arthur A, Moore M, Hippisley-Cox J (2015) Antidepressant use and risk of Epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database. BMC Psychiatry 15:315. https://doi.org/10.1186/s12888-015-0701-9

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J (2011) A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess 15 (28): 1-202, iii-iv https://doi.org/10.3310/hta15280

  13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012. https://doi.org/10.1001/jama.283.15.2008

    Article  PubMed  CAS  Google Scholar 

  14. Higgins JP (2014) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane collaboration. Available at: www.cochrane-handbook.org [6 December 2014]

  15. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186

    Article  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  17. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333(7568):597–600. https://doi.org/10.1136/bmj.333.7568.597

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bloechliger M, Ceschi A, Rüegg S, Kupferschmidt H, Kraehenbuehl S, Jick SS, Meier CR, Bodmer M (2016) Risk of seizures Associated with antidepressant use in patients with depressive disorder: follow-up study with a nested case-control analysis using the Clinical Practice Research Datalink. Drug Saf 39(4):307–321. https://doi.org/10.1007/s40264-015-0363-z

    Article  PubMed  CAS  Google Scholar 

  20. Sáez ME, González-Pérez A, Gaist D, Johansson S, Nagy P, García Rodríguez LA (2016) Risk of seizure associated with use of acid-suppressive Drugs: an observational cohort study. Epilepsy Behav 62:72–80. https://doi.org/10.1016/j.yebeh.2016.06.039

    Article  PubMed  Google Scholar 

  21. Wu CS, Liu HY, Tsai HJ, Liu SK (2017) Seizure risk Associated with antidepressant treatment among patients with depressive disorders: a Population-based case-crossover study. J Clin Psychiatry 78(9):e1226–e1232. https://doi.org/10.4088/JCP.16m11377

    Article  PubMed  Google Scholar 

  22. Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN (2018) Second-generation anti-depressants and risk of new-onset seizures in the elderly. Clin Toxicol (Phila) 56(12):1179–1184. https://doi.org/10.1080/15563650.2018.1483025

    Article  PubMed  CAS  Google Scholar 

  23. Chu CS, Lee FL, Bai YM, Su TP, Tsai SJ, Chen TJ, Hsu JW, Chen MH, Liang CS (2023) Antidepressant Drugs use and Epilepsy risk: a nationwide nested case-control study. Epilepsy Behav 140:109102. https://doi.org/10.1016/j.yebeh.2023.109102

    Article  PubMed  Google Scholar 

  24. Wiggs KK, Lagerberg T, Quinn PD, Öberg AS, Larsson H, Chang Z, D’Onofrio BM (2023) A nationwide study of initiation of antidepressant pharmacotherapy and the risk of seizures. Epilepsy Res 192:107134. https://doi.org/10.1016/j.eplepsyres.2023.107134

    Article  PubMed  CAS  Google Scholar 

  25. Karadag N, Shadrin AA, O’Connell K, Hindley GFL, Rahman Z, Parker N, Bahrami S, Fominykh V, Cheng W, Holen B, Alvestad S, Taubøll E, Steen NE, Djurovic S, Dale AM, Frei O, Andreassen OA, Smeland OB (2023) Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders. Brain DOI. https://doi.org/10.1093/brain/awad038

    Article  Google Scholar 

  26. Lesage F, Guillemare E, Fink M, Duprat F, Heurteaux C, Fosset M, Romey G, Barhanin J, Lazdunski M (1995) Molecular properties of neuronal G-protein-activated inwardly rectifying K + channels. J Biol Chem 270(48):28660–28667. https://doi.org/10.1074/jbc.270.48.28660

    Article  PubMed  CAS  Google Scholar 

  27. De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG (2014) Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 55(6):536–547. https://doi.org/10.1016/j.psym.2014.01.010

    Article  PubMed  Google Scholar 

  28. Halawa I, Andersson T, Tomson T (2011) Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia 52(2):410–413. https://doi.org/10.1111/j.1528-1167.2010.02939.x

    Article  PubMed  Google Scholar 

  29. Warden SJ, Fuchs RK (2016) Do selective serotonin reuptake inhibitors (SSRIs) cause fractures? Curr Osteoporos Rep 14(5):211–218. https://doi.org/10.1007/s11914-016-0322-3

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Biomedicine and health industry development technology project of Hangzhou (2023WJC019). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

AJL and WY searched the library and wrote the manuscript text. YHJ and HYJ extracted data and reviewed all articles. AJL designed the manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Ai-juan Li.

Ethics declarations

Conflict of interest

The authors declare no competing interest.

Details of ethical approval

No ethical approval was required for this review as all data were already published in peer-reviewed journals.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, W., Jia, Yh., Jiang, Hy. et al. Antidepressant use and the risk of seizure: a meta-analysis of observational studies. Eur J Clin Pharmacol 80, 175–183 (2024). https://doi.org/10.1007/s00228-023-03597-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-023-03597-y

Keywords

Navigation